RecruitingNCT07482176
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
PHASE3 · 534 planned enrolment
- Countries listed
- 1
- Registry update
- September 24, 2026
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–1 of 1. Every record below meets all the filters shown above.
PHASE3 · 534 planned enrolment